Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric B Suhler

Showing results (61-70 of 134) with videos related to

Pageof 14
Sort By:
Ophthalmology|March 15, 2015
Peripheral vascular leakage in uveitis: clinical and angiographic findingsJohn P Campbell, Robert M Beardsley, Neal V Palejwala, et al.
Ophthalmology. Retina|May 11, 2025
Prevalence, Treatment Patterns, and Outcomes of Pediatric Noninfectious Uveitis in the United States: An IRIS Registry AnalysisOgul E Uner, Phoebe Lin, Laura J Kopplin, et al.
Eye (London, England)|August 19, 2023
Characterization of autoimmune eye disease in association with Down's syndromeAmr M Zaki, Sirichai Pasadhika, Jerry C Huang, et al.
Molecular Vision|January 31, 2009
Genotype analysis of polymorphisms in autoimmune susceptibility genes, CTLA-4 and PTPN22, in an acute anterior uveitis cohortTammy M Martin, Louise Bye, Neil Modi, et al.
Ophthalmology|June 24, 2014
Rituximab therapy for refractory scleritis: results of a phase I/II dose-ranging, randomized, clinical trialEric B Suhler, Lyndell L Lim, Robert M Beardsley, et al.
JAMA Ophthalmology|March 22, 2014
Rituximab therapy for refractory orbital inflammation: results of a phase 1/2, dose-ranging, randomized clinical trialEric B Suhler, Lyndell L Lim, Robert M Beardsley, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|June 10, 2009
Infliximab therapy for refractory uveitis: 2-year results of a prospective trialEric B Suhler, Justine R Smith, Tracy R Giles, et al.
American Journal of Ophthalmology|June 27, 2008
Long-term risk of malignancy among patients treated with immunosuppressive agents for ocular inflammation: a critical assessment of the evidenceJohn H Kempen, Sapna Gangaputra, Ebenezer Daniel, et al.
Eye (London, England)|March 29, 2025
Electroretinography of disease activity and treatment response in birdshot chorioretinopathyChristopher R Rosenberg, Elizabeth White, Aseel Alsamarraie, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|September 13, 2014
Combination systemic and intravitreal antiviral therapy in the management of acute retinal necrosis syndromeSteven Yeh, Eric B Suhler, Justine R Smith, et al.
Pageof 14

Showing results (61-70 of 134) with videos related to

Sort By:
Pageof 14
Ophthalmology|March 15, 2015
Peripheral vascular leakage in uveitis: clinical and angiographic findingsJohn P Campbell, Robert M Beardsley, Neal V Palejwala, et al.
Ophthalmology. Retina|May 11, 2025
Prevalence, Treatment Patterns, and Outcomes of Pediatric Noninfectious Uveitis in the United States: An IRIS Registry AnalysisOgul E Uner, Phoebe Lin, Laura J Kopplin, et al.
Eye (London, England)|August 19, 2023
Characterization of autoimmune eye disease in association with Down's syndromeAmr M Zaki, Sirichai Pasadhika, Jerry C Huang, et al.
Molecular Vision|January 31, 2009
Genotype analysis of polymorphisms in autoimmune susceptibility genes, CTLA-4 and PTPN22, in an acute anterior uveitis cohortTammy M Martin, Louise Bye, Neil Modi, et al.
Ophthalmology|June 24, 2014
Rituximab therapy for refractory scleritis: results of a phase I/II dose-ranging, randomized, clinical trialEric B Suhler, Lyndell L Lim, Robert M Beardsley, et al.
JAMA Ophthalmology|March 22, 2014
Rituximab therapy for refractory orbital inflammation: results of a phase 1/2, dose-ranging, randomized clinical trialEric B Suhler, Lyndell L Lim, Robert M Beardsley, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|June 10, 2009
Infliximab therapy for refractory uveitis: 2-year results of a prospective trialEric B Suhler, Justine R Smith, Tracy R Giles, et al.
American Journal of Ophthalmology|June 27, 2008
Long-term risk of malignancy among patients treated with immunosuppressive agents for ocular inflammation: a critical assessment of the evidenceJohn H Kempen, Sapna Gangaputra, Ebenezer Daniel, et al.
Eye (London, England)|March 29, 2025
Electroretinography of disease activity and treatment response in birdshot chorioretinopathyChristopher R Rosenberg, Elizabeth White, Aseel Alsamarraie, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|September 13, 2014
Combination systemic and intravitreal antiviral therapy in the management of acute retinal necrosis syndromeSteven Yeh, Eric B Suhler, Justine R Smith, et al.
Pageof 14